Scienza e Tecnologia

Liquid Biopsy Market To Reach USD 6,804.9 Million By 2028 AT A CAGR Of 20.9% -…

View Full Reports: https://reports.valuates.com/reports/ALLI-Auto-1L160/liquid-biopsy View Full Reports: https://reports.valuates.com/reports/ALLI-Auto-1L160/liquid-biopsy Major factors driving the growth of the liquid biopsy market are: TRENDS INFLUENCING LIQUID BIOPSY MARKET An increase in the number of cancer patients is driving the liquid biopsy market. A liquid biopsy could aid in the detection of cancer at an early stage. It can also be used to aid in treatment planning,...
PR Newswire
20/07/2021

At 9.35% CAGR, Digital PCR Market Size to hit USD 955.1 Mn by 2027, says…

News: Stilla Technologies Launched the World's First Six-ColorDigital PCR Instrument News: Stilla Technologies Launched the World's First Six-ColorDigital PCR Instrument OnJanuary 9th2020; Stilla Technologies, a leading provider of digital PCR (dPCR) solutions for high-precision genetic analysis, launched the world's first six-color digital PCR instrument, the six-color Prism. The instrument expands the multiplexing capabilities of the company's digital PCR platform, the Naica System...
PR Newswire
20/07/2021

Eastman announces project with USAMP and PADNOS for fully circular recycling…

When automobiles are at the end of their life, metals, tires, and glass account for 80%–90% of the materials that can be recycled through traditional mechanical recycling streams. The other 10%–20%, referred to as automotive shedder residue (ASR), consists of mixed plastic and other non-recycled materials that currently end up in landfills or are recovered through waste-to-energy technologies. Under this initiative PADNOS will use ASR as a sustainable feedstock for Eastman's molecular recycling…
PR Newswire
20/07/2021

Well-Established Players Account for ~70 Percent Growth Share of the Sodium…

ALBANY, N.Y., July 20, 2021 /PRNewswire/ -- The escalating demand from various industries, including the packaging industry, pharmaceutical industry, packaging industry, and others will bring good growth prospects for the sodium borohydride market across the forecast period of 2019-2027. The increasing influence of sodium borohydride among a large number of sectors and businesses will prove to be a game-changer for the global market. ALBANY, N.Y.,July 20, 2021/PRNewswire/ -- The...
PR Newswire
20/07/2021

Low VOC Adhesives Market worth $63.3 Billion by 2026 - Exclusive Report by…

View Detailed Table of Content Here: https://www.marketsandmarkets.com/Market-Reports/low-voc-adhesive-market-168397836.htmlGrowing demand for Low VOC adhesives from Construction and Woodworking industries and environmental regulations in North America & Europe are the key driving factors for the market.Transportation is the fastest-growing segment of the overall Low VOC Adhesives Market.Transportation is the fastest-growing segment of the overall Low VOC Adhesives Market. In the automotive…
PR Newswire
20/07/2021

GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership

In collaboration with Insilico's AI-powered identification methods, GenFleet will enhance the exploration of the dynamic structure-activity relationship between target proteins and drug molecules through virtual structure research to develop highly selective inhibitors and deliver targeted therapies overcoming drug resistance. In collaboration with Insilico's AI-powered identification methods, GenFleet will enhance the exploration of the dynamic structure-activity relationship between target...
PR Newswire
20/07/2021

WPI-MANA Team Creates Flexible Patterning on Liquid Marble Droplets

Solid particles in the nanometer to micrometer size range irreversibly attach to liquid surfaces, which has led to new products and concepts, such as powder foam, dry water and liquid marbles (LMs). Solid particles in the nanometer to micrometer size range irreversibly attach to liquid surfaces, which has led to new products and concepts, such as powder foam, dry water and liquid marbles (LMs). LMs consist of droplets wrapped by hydrophobic solid particles, which behave as a non-wetting soft...
PR Newswire
20/07/2021

Intravacc's inactivated polio vaccine, out licensed to Sinovac, receives market…

- Intravacc's cell technology also used for the development of Sinovac's Covid-19 vaccine that was introduced on the market recently and is currently under rolling review by EMA - Intravacc's cell technology also used for the development of Sinovac's Covid-19 vaccine that was introduced on the market recently and is currently under rolling review by EMA BILTHOVEN,Netherlands,July 20, 2021/PRNewswire/ -- Intravacc, a world leader in translational research and development of...
PR Newswire
20/07/2021

SKF Half-year report 2021: Record operating profit

"The second quarter saw a record in adjusted operating profit of SEK 3,118 million (1,565 million) and an adjusted operating margin of 15.0% (9.4%). "The second quarter saw a record in adjusted operating profit ofSEK 3,118 million(1,565 million) and an adjusted operating margin of 15.0% (9.4%). The result was especially strong, given continued headwinds in the form of negative currency impact and rising input costs. Through mitigating actions we have been able to compensate for...
PR Newswire
20/07/2021

Pharming signs agreement with NewBridge Pharmaceuticals for the…

Under the terms of the agreement, NewBridge will work closely with Pharming to provide access for RUCONEST® for the treatment of acute hereditary angioedema ("HAE") in MENA. NewBridge will be responsible for the named patient supply and, where applicable, marketing of RUCONEST® in the region. Under the terms of the agreement, NewBridge will work closely with Pharming to provide access for RUCONEST® for the treatment of acute hereditary angioedema ("HAE") in MENA. NewBridge…
PR Newswire
20/07/2021

Bombardier Announces Redemption Price Calculation in Respect of its 5.750%…

The redemption date for the Notes is July 22, 2021, as set forth in the Notice. This press release does not constitute an offer to sell or buy or the solicitation of an offer to buy or sell any security and shall not constitute an offer, solicitation, sale or purchase of any securities in any jurisdiction in which such offering, solicitation, sale or purchase would be unlawful. The Notes mentioned herein have not been and will not be registered under the United States Securities Act...
Nasdaq GlobeNewswire
20/07/2021

Ensurge Micropower ASA - Warrant Exercise - Revised

Reference is made to the announcement by Ensurge Micropower ASA (the "Company") on 3 July 2021 regarding warrant exercises. The Company has subsequently noted that a timely Warrant C exercise notice by inadvertence had not been included in the earlier resolution by the board. Therefore, the board has amended and restated its resolution approving the warrant exercises and resulting share capital increase and the earlier stock exchange announcement on 3 July 2021 is hereby amended and…
Nasdaq GlobeNewswire
19/07/2021

DELTA DRONE -Drawdown of 1 tranche of ORNAN of €1.5M of nominal value

Drawdown of 1 tranche of ORNAN of €1 .5M of nominal valueDardilly , 19July2021 – 6pm In accordance with the authority granted to the Board of Directors by the Extraordinary General Shareholders' meeting of Delta Drone (the “Company”) dated 24 April 2020 pursuant to its sixth resolution, the Board of Directors dated 14 thOctober 2020: approved the principle of issuing 2 500 tranche warrants (the “TrancheWarrants”), giving access to 2 500...
Nasdaq GlobeNewswire
19/07/2021

LUMIBIRD IN EXCLUSIVE BID TO BUY AREVA'S STAKE IN CILAS

/07/2021 – 17h45 LUMIBIRD IN EXCLUSIVE BID TO BUY AREVA'S STAKE IN CILAS LUMIBIRD, the European leader for laser technologies, has signed an exclusive agreement with AREVA to acquire its 37% stake in CILAS. This acquisition will strengthen LUMIBIRD's key position in Europe in the defence and civil markets.The complementary nature of the CILAS and LUMIBIRD technology portfolios will enable them to benefit from dual (civil and military) technological synergies and constitute an offer and...
Nasdaq GlobeNewswire
19/07/2021

Agfa-Gevaert: Share buyback program – regulated information

Mortsel, Belgium – July 19, 2021 – 5:40 p.m. CET Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels. The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020.Agfa-Gevaert NV has requested a financial intermediary to repurchase Agfa-Gevaert shares...
Nasdaq GlobeNewswire
19/07/2021

Almirall receives European Commission approval of Klisyri®▼ (tirbanibulin), an…

Tirbanibulin is a novel, topical first-in-class microtubule inhibitor with a selective antiproliferative mechanism of action that represents a significant step forward in the treatment of AK due to its short treatment protocol -one application daily for 5 days-, proven efficacy and safety profile, with very acceptable local tolerability. Tirbanibulin is a novel, topical first-in-class microtubule inhibitor with a selective antiproliferative mechanism of action that represents a significant...
PR Newswire
19/07/2021

AV-Comparatives Releases Long-Term Enterprise Antivirus Test report for 19…

AV-Comparatives, a renowned security software evaluation institute, is pleased to release the year's first half-year report of the Business Main-Test Series for 2021. As many as 19 popular business cybersecurity products were examined in this rest series that consists of real-world protection test, malware protection test, and business speed impact test. The threat landscape continues to evolve rapidly, presenting antivirus vendors with new challenges. The test report shows how...
PR Newswire
19/07/2021

RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of…

Opaganib, a novel, dual antiviral and anti-inflammatory investigational COVID-19 pill, demonstrated potent inhibition of Beta and Gamma variants and is expected to be effective against emerging variants, including Delta and Delta Plus Opaganib, a novel, dual antiviral and anti-inflammatory investigational COVID-19 pill, demonstrated potent inhibition of Beta and Gamma variants and is expected to be effective against emerging variants, including Delta and Delta Plus TEL AVIV, Israeland...
PR Newswire
19/07/2021

EPDM Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™

Browse in-depth TOC on "EPDM Market" Browse in-depth TOC on "EPDM Market" 213 – Market Data Tables58 – Figures221 – Pages View Detailed Table of Content Here: https://www.marketsandmarkets.com/Market-Reports/epdm-rubber-market-483.html Automotive application holds the largest share in the EPDM market EPDM rubber account for significant portion of rubber parts that are utilized in automotive vehicle. In the automotive industry, EPDM is used in hoses, gaskets, body...
PR Newswire
19/07/2021

Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the…

Miro Venturi, Ph.D, MSc, is currently Chief Executive Officer at Sintetica, a Swiss pharmaceutical company, and previously he served as Chief Business Officer at Foundation Medicine, a leader in oncology molecular diagnostics part of Roche Group. He held several positions in Roche both in the Pharma and in the Diagnostics divisions. Miro Venturi, Ph.D, MSc, is currently Chief Executive Officer at Sintetica, a Swiss pharmaceutical company, and previously he served as Chief Business Officer at...
PR Newswire
19/07/2021

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to…

PEP-010 is the first of a new class of therapeutic peptides based on PEP-Therapy's innovative Cell Penetrating & Interfering Peptide (CP&IP) technology. These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, leading to the inhibition of key pathological mechanisms, without altering physiological mechanisms. PEP-010 is the first of a new class of therapeutic peptides based on PEP-Therapy's innovativeC ellP enetrating…
PR Newswire
19/07/2021

CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time…

CLD researchers looking to streamline upscaling and expansion workflows, which previously required weeks to complete, are sure to embrace the S.NEST's unique suspension culturing nourished by a continuous supply of oxygen. As part of CYTENA's extensive portfolio of single-cell instruments, the S.NEST will make highly efficient cell culturing results accessible to laboratories around the world. CLD researchers looking to streamline upscaling and expansion workflows, which previously required...
PR Newswire
19/07/2021

NKT Group updates 2021 financial outlook and resumes the review of strategic…

Company Announcement 16 July 2021Announcement No. 12 NKT Group updates 2021 financial outlook and resumesthereview of strategic alternatives for NKT Photonics Today, NKT Group provides preliminary financial figures for Q2 2021, updates the 2021 financial outlook and resumes the review of strategic alternatives for NKT Photonics.NKT CEO Alexander Kara says: - We have had a strong 1st half 2021 and the improved financial performance was driven by broad-based growth in...
Nasdaq GlobeNewswire
16/07/2021

Dassault Aviation: Description of share buyback program authorized 2021

DASSAULT AVIATION Frenchsociété anonymewith a share capital of EUR 66,789,624Registered office: 9, Rond-Point des Champs-Elysées Marcel Dassault75008 PARISRegistered on the Paris Trade and Company Register under number 712 042 456 Description of the share buyback program authorized by the Annual Ordinary and Extraordinary General Meeting of May 11, 2021 In accordance with the provisions of European Regulation (EU) No 596/2014 of April...
Nasdaq GlobeNewswire
16/07/2021
Altri  Comunicati